Anzeige
Mehr »
Login
Donnerstag, 03.10.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Citibank sagt $3.000 Gold voraus: Lernen Sie das Unternehmen kennen, das sich seit Jahren darauf vorbereitet
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
534 Leser
Artikel bewerten:
(2)

Leonardo DiCaprio Invests in Mosa Meat and Aleph Farms to Advance Development of Sustainable Cultivated Beef

DiCaprio joins two innovation powerhouses, as an investor and advisor, in growing global movement to transform the way meat is produced

MAASTRICHT, Netherlands and REHOVOT, Israel, Sept. 22, 2021 /PRNewswire/ -- Today, Aleph Farms and Mosa Meat, two companies leading the emerging field of cultivated meat, announce an investment from environmental activist and Academy Award winning actor, Leonardo DiCaprio. Both companies have demonstrated the ability to grow beef directly from animal cells, with the unveiling of the first cultivated hamburger by Mosa Meat in 2013 and the first cultivated steak and ribeye by Aleph Farms in 2018 and 2021, respectively.

Mosa Meat Logo

"One of the most impactful ways to combat the climate crisis is to transform our food system. Mosa Meat and Aleph Farms offer new ways to satisfy the world's demand for beef, while solving some of the most pressing issues of current industrial beef production. I'm very pleased to join them as an advisor and investor, as they prepare to introduce cultivated beef to consumers," said Leonardo DiCaprio.

With global meat consumption projected to grow 40-70% by 2050, cultivated meat offers a solution to greatly reduce the current negative impacts of industrial beef production. Additionally, cultivated meat will enable diners to enjoy the qualities of the meat they love, eliminating the need for any major behavioral change. Analysts have projected the cultivated meat market could reach $25 billion by 2030, as part of the broader protein transformation.

Maarten Bosch, CEO of Mosa Meat said: "Leonardo DiCaprio's work to bring about positive change is closely aligned with our mission at Mosa Meat. We are thrilled to bring him on board as advisor and investor and work together to feed current and future generations sustainably."

Didier Toubia, Co-Founder and CEO of Aleph Farms said: "As a committed environmentalist, we welcome Leonardo DiCaprio to our advisory board and family of top tier investors. Our team is committed to improving the sustainability of our global food systems and we're thrilled to have Leo share in our vision."

According to an independent Life Cycle Analysis study, cultivated beef production is projected to reduce climate impact by 92%, air pollution by 93%, use 95% less land and 78% less water when compared to industrial beef production. Cultivated beef production offers the opportunity to use the spare land for re-wilding habitats, which would naturally reduce emissions or for producing more food for people. Moreover, the automated process through which cultivated meat is produced, and the sterile environment of its manufacturing, will eliminate the use of antibiotics and greatly reduce the risk for pathogens, contaminants, and foodborne illnesses associated with concentrated and intensive animal farming.

About Aleph Farms
Aleph Farms grows beef steaks, from non-genetically engineered cells isolated from a living cow, without harming animals and with a significantly reduced impact to the environment. The company was co-founded in 2017 by Didier Toubia, The Kitchen Hub of the Strauss Group, and Professor Shulamit Levenberg from the Biomedical Engineering Faculty at the Technion - Israel Institute of Technology. Headquartered in Israel, Aleph Farms' global network of top tier investors includes L. Catterton, DisruptAD (ADQ), BRF, Thai Union and Cargill. Aleph Farms released the world's first cultivated steak in December 2018 and the world's first cultivated ribeye steak in 2021. The company's vision is to provide unconditional nutrition for anyone, anytime, anywhere. For more information, please visit www.aleph-farms.com.

About Mosa Meat

Mosa Meat is a global food technology company pioneering a cleaner, kinder way of making real beef. Our founders introduced the world's first cultivated beef hamburger in 2013, by growing it directly from cow cells. Founded in 2016, Mosa Meat is now scaling up production of the same beef that people love, but in a way that is better for people, animals, and the planet. A diverse and growing team of food-loving problem-solvers, we are united in our mission to fundamentally reshape the global food system.

Headquartered in Maastricht, The Netherlands, Mosa Meat is a privately held company backed by Blue Horizon, M Ventures, Bell Food Group, Nutreco, Mitsubishi Corporation and others. Follow Mosa Meat on Facebook, LinkedIn, Twitter and Instagram or visit mosameat.com to learn more about why people cravechange. Access the Mosa Meat press kit here.

All trademarks contained herein are the property of their respective owners.

Media Contacts:

Mercury Global Partners for Mosa Meat
Mindy M. Hull and Allie Gavan
+1 415 889 9977 (USA) / +1 415 987 7147 (USA)
+31 62 504 7680 (EU)
alephfarms@songuepr.com
mosameat@wearemgp.com

Songue PR for Aleph Farms
Natalee Gibson
+ 1 720 648 5784 (USA)

Logo - https://mma.prnewswire.com/media/1631014/Mosa_Meat_Logo.jpg
Logo - https://mma.prnewswire.com/media/1631015/Aleph_Farms_Logo.jpg

Aleph Farms Logo

© 2021 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.